The New Jersey decision ignores the fact that Johnson & Johnson has admitted in internal documents that its talc powder product carries a cancer risk. Read more
The class action complaint, which was filed in May 2014, alleges that Johnson & Johnson concealed from consumers the serious risks of ovarian cancer. Read more
Johnson & Johnson worked in concert with its talc supplier, Imerys Talc America, Inc., and the cosmetic trade organization, the Personal Care Products Council. Read more
Talcum powder litigation continues to move forward at a rapid pace and there have been a number of new developments this summer. Read more
Activity in our firm’s Mass Torts Section is at a record pace. Lawyers in the Section have been very busy on several fronts. They will investigate any potential claim involving a medication... Read more
We will start our first talc trial in St. Louis this month. Read more
It is with a heavy heart that I must report on the death of our client, Jacqueline Fox. This brave lady passed away on Oct. 6, 2015, after a two-year battle with ovarian cancer. In August, w... Read more
The first State Court talcum powder/ovarian cancer trial is scheduled to start on Feb. 1, 2016, in the Circuit Court of the City of St. Louis, Mo. It will involve claims brought by Jacquelin... Read more
Recently, Judge John Francis Garvey, Jr., of the Circuit Court of the City of St. Louis, Mo., denied motions to dismiss filed by defendants Johnson and Johnson, and Imerys Talc America. The... Read more
Lawyers in our firm are continuously being asked about what all our Mass Torts Section is doing. So we will again give an update on activity in the section. Lawyers in the Section will inves... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.